Lineage Cell Therapeutics, Inc.

Go to Lineage Cell Therapeutics, Inc. Website

$0.99

0.03 (3.43%)
Live
Previous Close

$0.9594

Day Range

$0.9573 - $1

Previous Day Range

$0.946 - $0.995

Market Cap

$221.5 million USD

Day Vol.

378636

Previous Day Vol.

794723

Currency

USD

Primary Exchange

NYSE American, LLC

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline is based on two platform technologies inclu...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

W.P. Carey, a diversified net lease REIT, reported Q2 2025 earnings with strong revenue growth and AFFO per share, despite experiencing net income decline due to non-cash market adjustments. The company raised full-year guidance and increased quarterly dividend.

Related tickers: WPC, LCTX.

Read Full Article

The global refrigerated warehousing market is expected to grow significantly, driven by the surge in e-commerce, particularly in the grocery and food sectors, as well as advancements in cold storage technologies and the rising demand for temperature-sensitive products.

Related tickers: LCTX, COLD.

Read Full Article
Trending Tickers

Please sign in to view